Jacquelyn Sumer
Compliance Officer chez CULLINAN THERAPEUTICS, INC.
Fortune : 2 M $ au 30/04/2024
Postes actifs de Jacquelyn Sumer
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CULLINAN THERAPEUTICS, INC. | Compliance Officer | 15/08/2022 | - |
| Conseiller Juridique Général | 15/08/2022 | - | |
| Secrétaire Général | 15/08/2022 | - |
Historique de carrière de Jacquelyn Sumer
Anciens postes connus de Jacquelyn Sumer
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CELGENE | Directeur/Membre du Conseil | 01/05/2017 | 01/07/2018 |
| Corporate Officer/Principal | 01/05/2017 | 01/07/2018 | |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - | - |
| GENOCEA BIOSCIENCES, INC. | Compliance Officer | 01/02/2021 | - |
| Conseiller Juridique Général | 01/02/2021 | - |
Formation de Jacquelyn Sumer
| Duke University School of Law | Graduate Degree |
| Bucknell University | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 7 |
Opérationnelle
| Compliance Officer | 2 |
| General Counsel | 2 |
| Corporate Officer/Principal | 2 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| GENOCEA BIOSCIENCES, INC. | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| CULLINAN THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
- Bourse
- Insiders
- Jacquelyn Sumer
- Expérience